RealClearHealth October 22, 2015 Archives

RealClearHealth AM Update

House GOP Drops Part of Obamacare Repeal

Sarah Ferris The Hill

Obama Announces Steps to Combat Opiate Abuse

Mufson & Zezima WP

Valeant Denies Report that Bludgeoned Stock

Ed Silverman Pharmalot

Drug Makers Respond on Specialty Pharmacies

Chelsey Dulaney WSJ

Medicare Increases Await Serious Talks in Congress

Jon Reid MC

NIH Funding Caught in Budget Battle

Caitlin Owens National Journal

Novartis Tests Pricing Model w/ Heart Failure Rx

Ben Hirschler Reuters

Theranos Defends Its Accuracy

Katie Benner New York Times

New Screening Won't Assure Fewer Mammograms

Aaron Carroll Upshot

Biden Calls for 'Moonshot' to Cure Cancer

Dylan Scott Stat

Daraprim Price Hike and a Role for Antitrust

Carrier & Kesselheim HA

Hospital Routines May Make Patients Sicker

Madeline Kennedy Reuters

Looking Under the Valeant Pharmaceuticals Rock

Derek Lowe Science

Clinton Doesn't Like Insurer Mergers. So What?

Brooke Sutherland BV

ONC Interoperability Plan: Late & $19B Short

Tom Giannulli THCB

RealClearHealth PM Update

GAO: Marketplaces Vulnerable to Errors in Coverage

Robert Pear NYT

S.C. Co-op Shutting Down, Blames Risk Corridors

John McDermott P&C

Wyoming's WINhealth to Exit the Insurance Market

Becky Orr WTE

Crunch Time for Small Biz as Mandate Looms

Joyce M. Rosenberg AP

Study: Doctors Passively Discourage HPV Vaccine

Helen Branswell Stat

Navigating the Maze of Electronic Health Records

Rachel Roubein NJ

Answer to Drug Prices Is More Drugs, Faster

Coburn & Howard WSJ

The Battle over Calif. Crisis Pregnancy Centers

Dahlia Lithwick Slate

RealClearHealth Research and Analysis

Cadillac Tax vs. Cap on Tax Exclusion of Benefits

Urban Institute